Comparison of clinical features and treatment outcome of breast cancers in young and elderly Chinese patients

Breast Care

Volumn 6, Issue 6, 2011, Pages 435-440

  Tang, Jun ^a,b   Wu, Chu Cheng ^c   Xie, Ze Ming ^a,b   Luo, Rong Zhen ^a,b   Yang, Ming Tian ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c HUIZHOU MUNICIPAL CENTRAL HOSPITAL   (China)

Author keywords

Breast cancer; Elderly women; Molecular subtypes; Prognostic features; Very young women

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHINA; CLINICAL FEATURE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 84455193302     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000332593     Document Type: Article

References (23)

1. Gennari R, Curigliano G, Rotmensz N, Robertson C, Colleoni M, Zurrida S, Nole F, de Braud F, Orlando L, Leonardi MC, Galimberti V, Intra M, Veronesi P, Renne G, Cinieri S, Audisio RA, Luini A, Orecchia R, Viale G, Goldhirsch A: Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients. Cancer 2004;101:1302-1310. (Pubitemid 39180385)
2. Han W, Kim SW, Park IA, Kang D, Kim SW, Youn YK, Oh SK, Choe KJ, Noh DY: Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 2004;4:82.
3. Colleoni M, Rotmensz N, Robertson C, Orlando L, Viale G, Renne G, Luini A, Veronesi P, Intra M, Orecchia R, Catalano G, Galimberti V, Nole F, Martinelli G, Goldhirsch A: Very young women (〈 35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 2002;13:273-279. (Pubitemid 34704980)
4. Chia KS, Du WB, Sankaranarayanan R, Sankila R, Wang H, Lee J, Seow A, Lee HP: Do younger female breast cancer patients have a poorer prognosis? Results from a population-based survival analysis. Int J Cancer 2004;108:761-765. (Pubitemid 38076409)
5. Cancello G, Maisonneuve P, Rotmensz N, Viale G, Mastropasqua MG, Pruneri G, Veronesi P, Torrisi R, Montagna E, Luini A, Intra M, Gentilini O, Ghisini R, Goldhirsch A, Colleoni M: Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (〈 35 years) with operable breast cancer. Ann Oncol 2010;21:1974-1981.
6. Rapiti E, Fioretta G, Verkooijen HM, Vlastos G, Schafer P, Sappino AP, Kurtz J, Neyroud-Caspar I, Bouchardy C: Survival of young and older breast cancer patients in Geneva from 1990 to 2001. Eur J Cancer 2005;41:1446-1452. (Pubitemid 40826469)
7. Barchielli A, Balzi D: Age at diagnosis, extent of disease and breast cancer survival: a population-based study in Florence, Italy. Tumori 2000;86:119-123. (Pubitemid 30304401)
8. Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M: Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 2000;320:474-478. (Pubitemid 30173116)
9. La Rosa F, Patavino VM, Epifani AC, Petrinelli AM, Minelli L, Mastrandrea V: Ten-year survival and age at diagnosis of women with breast cancer from a population-based study in Umbria, Italy. Tumori 1996;82:441-443.
10. Yang MT, Rong TH, Huang ZF, Zeng CG, Long H, Fu JH, Lin P, Wang X, Wang SY, Wang X, Tang J: (Clinical analysis of resectable breast cancer: a report of 6 263 cases). Ai Zheng 2005;24:327-331.
11. Carey LA, Perou CM, Livasy CA, Dressler LG,Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC: Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006;295:2492-2502. (Pubitemid 43854964)
12. Han W, Kang SY: Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res Treat 2010;119:193-200.
13. Walker RA, Lees E, Webb MB, Dearing SJ: Breast carcinomas occurring in young women (< 35 years) are different. Br J Cancer 1996;74:1796-1800. (Pubitemid 26401901)
14. Chung M, Chang HR, Bland KI, Wanebo HJ: Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 1996;77:97-103. (Pubitemid 26002742)
15. Winchester DP, Osteen RT, Menck HR: The national cancer data base report on breast carcinoma characteristics and outcome in relation to age. Cancer 1996;78:1838-1843. (Pubitemid 26330915)
16. Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL: Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 2008;26:3324-3330.
17. Grady D: Clinical practice. Management of menopausal symptoms. N Engl J Med 2006;355:2338-2347. (Pubitemid 44837782)
18. Maggard MA, O'Connell JB, Lane KE, Liu JH, Etzioni DA, Ko CY: Do young breast cancer patients have worse outcomes? J Surg Res 2003; 113:109-113. (Pubitemid 36999799)
19. Althuis MD, Brogan DD, Coates RJ, Daling JR, Gammon MD, Malone KE, Schoenberg JB, Brinton LA: Breast cancers among very young premenopausal women (united states). Cancer Causes Control 2003;14:151-160. (Pubitemid 36539521)
20. Montella M, Crispo A, D'Aiuto G, De Marco M, de Bellis G, Fabbrocini G, Pizzorusso M, Tamburini M, Silvestra P: Determinant factors for diagnostic delay in operable breast cancer patients. Eur J Cancer Prev 2001;10:53-59. (Pubitemid 32200202)
21. Schreer I: Dense breast tissue as an important risk factor for breast cancer and implications for early detection. Breast Care (Basel) 2009;4:89-92.
22. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V: Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and Her2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer 2007;109:1721-1728. (Pubitemid 46668532)
23. Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Orlando L, Ghisini R, Viale G, Pruneri G, Veronesi P, Luini A, Intra M, Cardillo A, Torrisi R, Rocca A, Goldhirsch A: Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease. Ann Oncol 2006;17:1497-1503. (Pubitemid 44542034)